Literature DB >> 28834100

The epidemiology of hepatitis B virus infection in women of reproductive age in highly endemic areas in China.

H Zheng1, F Q Cui1, F Z Wang1, L F Huang2, X P Shao3, J F Du4, J Li5, Y Zhou2, H Z Zheng3, J T Zhuo4, X X Zeng5, G M Zhang1, N Miao1, X J Sun1, X F Liang1, H M Luo1.   

Abstract

We describe the epidemiology of hepatitis B virus (HBV) infection among women of reproductive age residing in areas of China that are highly endemic for chronic HBV, and provide evidence useful for decision-makers to guide strategies for preventing mother-to-child transmission of HBV, and assess the impact of perinatal transmission PMTCT by projecting HBsAg prevalence trends without interventions. We conducted a cross-sectional HBV serological survey of women, 15-49 years of age, residing in Fujian, Guangdong, Guangxi and Hainan provinces. Demographic and other subject-level data were collected in face-to-face interviews, after which we obtain blood specimens. Specimens were tested for HBV sero-markers by ELISA (Beijing Wantai Biological Pharmacy), and HBV DNA was tested with PCR (Hunan Sansure Biotech). Weighted HBsAg and HBV (either HBsAg+ or anti-HBc+ indicating either present or past infection) prevalences were 11.82% and 57.16%, respectively. Among the HBsAg-positive women, 27% were also HBeAg positive. The proportion of individuals with HBV DNA loads >105 IU/mL declined with increasing age. Among HBsAg-negative women, 0.9% had occult HBV infection. The prevalence of chronic HBV infection among reproductive women in these highly endemic provinces is high, posing a threat to maternal health and risk of mother-to-child transmission. Prevention of mother-to-child transmission remains critically important.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  HBV infection; epidemiology; reproductive age women

Mesh:

Substances:

Year:  2017        PMID: 28834100     DOI: 10.1111/jvh.12757

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  5 in total

1.  The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission.

Authors:  Guo Yonghao; Chen Yanping; Dou Qiaohua; Feng Daxing; Zhang Yanyang; Zhao Dongyang; Guo Wanshen
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

2.  New progress towards elimination of mother-to-child transmission of hepatitis B virus in China.

Authors:  Hui Zheng; Nick Walsh; Olufunmilayo Lesi; Fuqiang Cui
Journal:  Hepatol Int       Date:  2022-10-18       Impact factor: 9.029

3.  Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in China.

Authors:  Hui Zheng; Guo-Min Zhang; Po-Lin Chan; Fu-Zhen Wang; Lance Everett Rodewald; Ning Miao; Xiao-Jin Sun; Zun-Dong Yin; Jeffrey Edwards; Hua-Qing Wang
Journal:  Infect Dis Poverty       Date:  2019-07-04       Impact factor: 4.520

4.  Prevalence of HBsAg among reproductive age couples in Chongqing: A population-based, cross-sectional study.

Authors:  Qing Chen; Jun Liu; Yang He; Liu Yang; Huiqiang Luo; Yixi Wang; Xuewen Zhang; Ningxiu Li
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

5.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.